The actin cytoskeleton undergoes architectural changes during the processes
of cell transformation and tumourigenesis, Transforming growth factors bet
a arrest cell cycle progression, regulate differentiation and modulate the
onset of oncogenesis and tumourigenesis. Here, we investigated the direct r
ole of transforming growth factor beta-1 in altering the transformed phenot
ype and regulating the actin organisation of oncogenic fibroblasts that con
stitutively or inducibly express the H-ras oncogene, Following transforming
growth factor P-l treatment, these transformed fibroblasts undergo a drama
tic morphological alteration that includes a discrete reorganisation of the
ir actin cytoskeleton and focal adhesions, Quantitative biochemical analysi
s demonstrated that transforming growth factor P-l potently induced polymer
isation of globular to filamentous:actin, thus corroborating the morphologi
cal analysis, The effect of transforming growth factor beta-1 on the cytosk
eleton correlates with the ability of this cytokine to suppress anchorage-i
ndependent growth of the transformed fibroblasts, Furthermore, transforming
growth factor P-l upregulates considerably the levels of the RhoB small GT
Pase and less the RhoA levels, Finally, The Rho GTPase inhibitor, C3 exotra
nsferase, blocks the ability of TGF-beta 1 to induce cytoskeletal reorganis
ation, These findings indicate that transforming growth factor beta can reg
ulate cell morphology and growth in a concerted manner possibly via mechani
sms that control the actin cytoskeleton.